CPWM LLC’s INTERLEUKIN GENETICS INC ILI Stock Holding History

CPWM LLC’s Portfolio ILI Stock Details ILI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-302,271	Closed	-$1K	–	330
2017 Q4	$1K	Sell	302,271 -920,593	-75%	-$3.04K	﹤0.01%	226
2017 Q3	$38K	Buy	1,222,864 +611,432	+100%	+$19K	0.01%	229
2017 Q2	$36K	Hold	611,432	–	–	0.01%	253
2017 Q1	$69K	Buy	+611,432	New	+$69K	0.02%	242
2016 Q4	–	Sell	-611,432	Closed	-$119K	–	281
2016 Q3	$119K	Hold	611,432	–	–	0.03%	258
2016 Q2	$79K	Hold	611,432	–	–	0.02%	266
2016 Q1	$67K	Hold	611,432	–	–	0.01%	267
2015 Q4	$36K	Hold	611,432	–	–	0.01%	272
2015 Q3	$49K	Buy	611,432 +255,000	+72%	+$20.4K	0.01%	265
2015 Q2	$46K	Buy	356,432 +54,161	+18%	+$6.99K	0.01%	212
2015 Q1	$42K	Hold	302,271	–	–	0.01%	155
2014 Q4	$42K	Hold	302,271	–	–	0.01%	164
2014 Q3	$45K	Hold	302,271	–	–	0.02%	136
2014 Q2	$91K	Hold	302,271	–	–	0.03%	127
2014 Q1	$106K	Hold	302,271	–	–	0.04%	119
2013 Q4	$106K	Hold	302,271	–	–	0.04%	113
2013 Q3	$127K	Hold	302,271	–	–	0.05%	107
2013 Q2	$127K	Buy	+302,271	New	+$127K	0.05%	107

CPWM LLC's ILI Position: Q1 2018 in Review

CPWM LLC sold out of INTERLEUKIN GENETICS INC (ILI) in Q1 2018, closing a stake of 302,271 shares — an estimated $1K sold.

CPWM LLC first reported a position in ILI in Q2 2013 and held it in 18 quarters. The position peaked at $127K in Q3 2013. 0 funds tracked by Wall St. Rank hold ILI as of Q1 2018.

CPWM LLC reported no remaining INTERLEUKIN GENETICS INC position as of Q1 2018 after selling out during the quarter.
CPWM LLC sold 302,271 INTERLEUKIN GENETICS INC shares in Q1 2018, an estimated $1K.
CPWM LLC first reported a position in INTERLEUKIN GENETICS INC in Q2 2013 and held it in 18 quarters.
CPWM LLC's INTERLEUKIN GENETICS INC position peaked at $127K in Q3 2013.
0 funds tracked by Wall St. Rank held INTERLEUKIN GENETICS INC as of Q1 2018.

Based on CPWM LLC's 13F filing for Q1 2018, filed 15 May 2018.